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Bipolar disorder, also known as manic-depressive
illness, causes swings in mood and activity levels at
irregular intervals. Such changes are difficult to pre-
dict, and their molecular basis remains unknown.
Here, we use infradian (longer than a day) cyclic ac-
tivity levels in aCaMKII (Camk2a) mutant mice as a
proxy for such mood-associated changes. We report
that gene-expression patterns in the hippocampal
dentate gyrus could retrospectively predict whether
the mice were in a state of high or low locomotor ac-
tivity (LA). Expression of a subset of circadian genes,
as well as levels of cAMP and pCREB, possible up-
stream regulators of circadian genes, were corre-
lated with LA states, suggesting that the intrinsic
molecular circuitry changes concomitant with infra-
dian oscillatory LA. Taken together, these findings
shed light onto the molecular basis of how irregular
biological rhythms and behavior are controlled by
the brain.INTRODUCTION
Mood changes occur in an infradian rhythm (Bryson and Martin,
1954; Eastwood et al., 1985) and affect a variety of biological
functions, including neuronal and motor activities (Chen et al.,
2010; Wolff et al., 1985). However, elucidation of the molecular
basis of such changes has been hampered by the lack of animal
models exhibiting spontaneous behavioral changes related to
the infradian oscillation of mood. In our previous work, we found
that mice with heterozygous knockout of the alpha-isoform of
calcium/calmodulin-dependent protein kinase II (Camk2a-HKO
mice) show various dysregulated behaviors, including infradian
oscillation of locomotor activity (LA; Hagihara et al., 2013; Shin
et al., 2013; Yamasaki et al., 2008), suggesting that Camk2a-
HKO mice may serve as an animal model showing infradian
oscillation of mood, which is substantially found in patients2784 Cell Reports 14, 2784–2796, March 29, 2016 ª2016 The Authorwith bipolar disorder (Belmaker, 2004). CAMK2 has been impli-
cated in mood disorders, including bipolar disorder and depres-
sion (Robison, 2014; Xing et al., 2002), as well as autism (Lanz
et al., 2013), which is highly comorbid with mood disorders (Ma-
zefsky et al., 2008). A recent study revealed genetic associations
of CAMK genes, including CAMK2A, with bipolar disorder
(Ament et al., 2015). A nonsense mutation and a splice-donor
mutation were reported in CAMK2A and CAMK2B, respectively,
in schizophrenia patients in an exome-sequencing study (Purcell
et al., 2014). A meta-analysis integrating genetics and genomics
of human and animal model data also identified Camk2a as one
of the ‘‘top candidate genes’’ for bipolar disorder (Le-Niculescu
et al., 2009). Further evidence supports that the Camk2a-HKO
mice have construct and face validity as a model of mood disor-
ders, including bipolar disorder. At the cellular level, these
mutant mice exhibit maturation abnormalities in the granule cells
of the hippocampal dentate gyrus (DG), in which the molecular
and physiological properties are similar to those of normal imma-
ture granule cells (Yamasaki et al., 2008). The maturation abnor-
mality of DG has been found in the postmortem brain of patients
with bipolar disorder and schizophrenia (Walton et al., 2012). In
addition, neuronal hyperexcitability, which we previously de-
tected in the hippocampal DG of Camk2a-HKO mice (Hagihara
et al., 2013; Yamasaki et al., 2008), was also found in the DG
granule cell-like neurons differentiated from induced pluripotent
stem cells (iPSCs) of patients with bipolar disorder (Mertens
et al., 2015). At a behavioral level, Camk2a-HKO mice exhibit
additional abnormal behaviors, such as deficits in social activity
and working memory, which are analogous to those in patients
with bipolar disorder and schizophrenia (Yamasaki et al.,
2008). Here, we focused on the unique behavioral phenotype
of infradian oscillatory LA exhibited by this mouse model with
high validity for mood disorders.
Because the DG is thought to be involved in the regulation of
mood (David et al., 2010; Samuels and Hen, 2011), we hypothe-
sized that the gene expression patterns in the DG may retain in-
formation about infradian oscillatory LA. In the present study, we
examined whether gene expression patterns in the DG could
predict LA in Camk2a-HKO mice by applying a statistical
learning algorithm, which could discover intrinsic links betweens
Figure 1. Experimental Overview for Predicting LA from Gene Expression Patterns
(A) LA data were acquired with a home cage monitoring system by measuring the distance traveled in the cage.
(B and C) LA was monitored. (B) Following the monitoring of LA, the DG was taken from each mouse ZT6–ZT7. (C) 24-hr LA, distance traveled during the 24 hr
before ZT0 on the sampling day; 3-hr LAs, LAs of every 3-hr window before sampling (ZT6).
(D) The DG was processed for microarray analysis.
(E) Statistical learning models were built using gene expression profiles to predict LA during the time windows of interest.
See also Figure S1 and Table S1.these molecular signatures and LA. This approach was inspired
by the analogy of neural decoding methods, in which statistical
learning models predict specific mental contents from human
functional MRI patterns (Horikawa et al., 2013; Miyawaki et al.,
2008). Statistical learning methods using microarray data have
been employed for class predictions (Michiels et al., 2005;
Reis-Filho and Pusztai, 2011). Regarding class prediction of
behavior, gene expression patterns in the brain can discriminate
between two classes of behavior in honeybees (Whitfield et al.,
2003). Unlike such class predictions, we sought to conduct
quantitative predictions of LA from gene expression patterns in
the brain.
RESULTS
LA in the Home Cage Is Correlated with Anxiety- and
Depression-like Behaviors in Camk2a-HKO Mice
To examine whether infradian oscillatory LA in the home cages of
Camk2a-HKO mice is associated with traditional measures ofCellanxiety- and depression-like behaviors, we conducted an open
field test and the Porsolt forced swim test following measure-
ment of home cage LA. The behavioral tests were performed
from zeitgeber time (ZT) 6 (ZT0, lights on; ZT12, lights off).
The total distance traveled in the open field was not correlated
with the level of home cage LA, as represented by 24-hr LA (dis-
tance traveled during the 24 hr between ZT0 of the day before the
tests and ZT0 of the day of the tests; Figures 1B and 1C; Fig-
ure S1A). This indicated that changes in home cage LA were
not caused by general problems in physical activity (Figure S1B).
Time spent in the center of the open field apparatus, which is
considered an index of anxiety-like behavior, positively corre-
lated with 24-hr LA in the home cage (Figure S1C). In the forced
swim test, the percentage of immobility time was negatively
correlated with 24-hr LA in the home cage (Figures S1D and
S1E). These results suggested that the LA state in the home
cage was correlated with anxiety- and depression-like behav-
iors, potentially reflecting a certain state of mood in Camk2a-
HKO mice.Reports 14, 2784–2796, March 29, 2016 ª2016 The Authors 2785
LA of Mice Can Be Retrospectively Predicted from Gene
Expression Profiles in the Hippocampal DG
An experimental overview for predicting LA from gene expres-
sion patterns in the DG is depicted in Figure 1. We monitored
LA in the home cage (Figure 1A) for 72–82 days using 37
Camk2a-HKO mice (Figure 1B). Following longitudinal moni-
toring, the DG was sampled ZT6–ZT7 (Figure 1C) and was pro-
cessed for transcriptomic analysis (Figure 1D). Mice were
selected for the sampling such that their 24-hr LA levels varied
among the 37 mice (Figures 1C and 2A). Of 45,037 transcripts
tested, the expression levels of 864 transcripts (817 genes)
were correlatedwith the 24-hr LA (p < 0.01, Pearson’s correlation
coefficient), and 60 transcripts survived false discovery rate
correction for multiple tests (q value < 0.1; Table S1). Pathway
analysis using KeyMolnet, a literature-based knowledgebase
containing highly reliable information on a range of human pro-
teins, small molecules, molecular relations, and diseases (Satoh
and Tabunoki, 2011), revealed that bipolar disorder was the dis-
ease most relevant to the genes exhibiting high correlations with
24-hr LA (p < 0.0005, 111 transcripts; Table 1). To determine
whether gene expression patterns in the DG could retrospec-
tively predict 24-hr LA of individual mice, we performed an out-
of-sample prediction test, in which independent sets of mice
were used for training (including feature selection from the entire
set of 45,037 transcripts) and testing a linear regression model
that predicted 24-hr LA from transcriptome data (Figures 1E
and 2B). Correlations between the actual and the predicted
24-hr LAwere significant (Figure 2C), revealing that gene expres-
sion patterns in the DG could accurately predict 24-hr LA.
To investigate whether gene expression patterns in the DG
could predict the LA of the past several days, we constructed
gene expression-based models for predicting the LA of every
3-hr window (3-hr LA) within the 5 days before sampling (yielding
40 time windows). The actual and the predicted 3-hr LAs were
similar to each other for the past 3–4 days in almost all mice;
however, differences gradually appeared at 4 or more days
before sampling (Figure 2D; Figure S2). Statistical evaluation of
prediction accuracy of the models detected significant correla-
tions between the actual and the predicted 3-hr LAs at 6 of 40
time windows after Bonferroni correction for multiple tests (Fig-
ures 2E–2K). The oldest time window with significant correlation
was from 117 to 114 hr before sampling. Thus, the gene expres-
sion-based models can successfully predict 3-hr LAs of the past
5 days, suggesting that the gene expression in the DG would
hold the information about LA for the past several days. Notably,
three of the six time windows were within 24 hr before sampling
(Figures 2F–2H). However, gene expression patterns in the DG
could not predict 3-hr LA immediately before sampling (Fig-
ure 2E). The expression levels of some major neuronal activity-
regulated genes were correlated with the 3-hr LA, as well as
LA during 60 min immediately before sampling, but not with
24-hr LA (Table 2), suggesting that expression patterns of genes
correlated with LA immediately before sampling, including the
known neuronal activity-regulated genes, do not have prediction
ability for infradian states of LA.
Focusing on the six previously mentioned time windows (Fig-
ure 2E), we examined differences between the gene sets used in
those prediction models. At three time windows within the 24 hr2786 Cell Reports 14, 2784–2796, March 29, 2016 ª2016 The Authorbefore sampling, similar genes were used in the prediction
models (Table S2). However, genes used in the prediction
models of 3-hr LAs 3–5 days before sampling generally differed
(Table S2), suggesting that the expression of distinct sets of
genes in the DGmay retain information about LA during different
and specific time windows.
Expression Levels of Circadian Genes in the DG Are
Correlated with LA
Prediction analysis of microarray data was implemented to find
which genes are most useful to characterize the behavioral state
of individual mice (Chemello et al., 2011; Kittleson and Hare,
2005; Whitfield et al., 2003). The prediction algorithm we used
identified gene signatures related to infradian oscillatory LA by
weighting genes according to their individual predictive strength.
Thus, we tried to find molecular alterations accompanying
changes in LA by examining the weighted genes used for 24-hr
LA prediction at least one time in linear regression (Figure 3A).
Our preliminary survey on the genes exhibiting correlation with
24-hr LA (Table S1) using the Database for Annotation, Visualiza-
tion and Integrated Discovery (DAVID) bioinformatics tool
showed significant enrichment for pathways or biogroups,
such as immunoglobulin I set, steroid biosynthesis, and biolog-
ical rhythms (Benjamini-adjusted p < 0.05). This result led us to
notice that some well-known circadian genes, such as Arntl
(Bmal1) and Tef, are in the predictive gene list (Figure 3A). The
reliability of the prediction analysis of the microarray data was
supported by the presence of genes known to be associated
with mood disorder, such as bipolar disorder (Grm4 and
Bmal1, Kato, 2007; Fam107a, Nakajima and Koizumi, 2014)
and depression (Tef, Hua et al., 2012, 2014). In addition, dysre-
gulated expression of Sfpq (Kubota et al., 2010; Nakatani
et al., 2006) was reported in the brain of patients with bipolar
disorder. Then, we determined how many circadian genes
were included in the list by querying the Photoperiodism data-
base (http://photoperiodism.brainstars.org/rhythmic/), which
describes genes showing a 24-hr rhythm in the mouse pars tu-
beralis (Masumoto et al., 2010). Of the 29 transcripts, 7 were
circadian genes (Figure 3A); this was significantly higher than
the chance level (c2(1) = 56.85, p = 4.70 3 1014), which was
determined as the percentage of transcripts present in the
Photoperiodism database (1,107) among the transcripts exam-
ined in the DG of Camk2a-HKO mice (45,037). When applying
the same analysis to the list of genes exhibiting correlations
with 24-hr LA (p < 0.01), we found a significantly larger number
of circadian genes than chance level in the list (55 of 864 tran-
scripts, c2(1) = 55.03, p = 1.19 3 1013; Table S1). In the gene
sets used in successful predictions of 3-hr LA, circadian genes
were found in three time windows within the 24 hr before sam-
pling but were not found in three earlier time windows (Table
S2). These findings suggested that circadian genes may specif-
ically correlate with LA within the past 24 hr in the DG.
For the respective top ten circadian genes showing positive
and negative correlations with 24-hr LA, the direction of correla-
tion between circadian gene expression and 24-hr LA matched
their circadian phase (Figures 3B and 3C). The circadian phase
represents the peak time of diurnal oscillation of gene expression
(Figure 3B; Masumoto et al., 2010). Genes whose expressions
Figure 2. LA of Mice Could Be Retrospectively Predicted from Gene Expression Profiles in the DG
(A) Distribution of 24-hr LA for 37 Camk2a-HKO mice.
(B) Illustration of an out-of-sample prediction test.
(C) Prediction of 24-hr LA from gene expression patterns in the DG of Camk2a-HKOmice. The scatter plot shows significant correlations between predicted and
actual LAs (n = 37 mice, r = 0.747, p = 1.11 3 107).
(D) Prediction of 3-hr LAs during the 5 days before sampling. The prediction results of 15 mice are shown; the results of the remaining 22 mice are shown in
Figure S1.
(E) Correlation coefficients between the actual and the predicted 3-hr LAs at each time window. Asterisks indicate statistically significant correlations between
actual and predicted 3-hr LAs after Bonferroni correction (p < 0.00125 = 0.05/40).
(F–K) Scatter plots of predicted and actual 3-hr LAs of each mouse at the time windows indicated in (E).
See also Figure S2 and Table S2.
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Table 1. Diseases and Pathways Relevant to the Genes
Exhibiting High Correlations with 24-hr LA
Rank Name Score Score (p)
Disease
1 bipolar disorder 49.60 1.17 3 1015
2 chronic myelogenous leukemia 38.60 2.40 3 1012
3 viral myocarditis 37.11 6.74 3 1012
4 mantle-cell lymphoma 33.45 8.53 3 1011
5 neuroblastoma 31.51 3.28 3 1010
6 metabolic syndrome 30.92 4.92 3 1010
7 adult T cell lymphoma/leukemia 30.76 5.51 3 1010
8 prostate cancer 26.08 1.41 3 108
9 colorectal cancer 25.44 2.20 3 108
10 viral hepatitis 22.82 1.35 3 107
11 bladder cancer 22.71 1.46 3 107
12 ovarian cancer 21.62 3.11 3 107
13 depression 21.17 4.25 3 107
14 autism 20.93 5.01 3 107
15 small cell lung cancer 20.64 6.13 3 107
16 hepatitis 20.60 6.27 3 107
17 amyotrophic lateral sclerosis 17.41 5.76 3 106
18 osteoporosis 16.97 7.77 3 106
19 hypergranular promyelocytic
leukemia
16.37 1.18 3 105
20 pancreatic cancer 15.55 2.09 3 105
20 non-small cell lung cancer 15.55 2.09 3 105
Pathway Based on Molecule
1 p160 SRC signaling pathway 78.40 2.51 3 1024
2 Transcriptional regulation by
SMAD
69.56 1.15 3 1021
3 ING signaling pathway 59.53 1.20 3 1018
4 Transcriptional regulation by
androgen receptor
57.59 4.62 3 1018
5 Mst (Hippo) signaling pathway 51.38 3.41 3 1016
6 Bcl-2 family signaling pathway 50.63 5.75 3 1016
7 Arrestin signaling pathway 50.38 6.81 3 1016
8 Transcriptional regulation by CREB 50.06 8.52 3 1016
9 HSP90 signaling pathway 49.52 1.24 3 1015
10 MAPK signaling pathway 48.27 2.95 3 1015
11 Transcriptional regulation by NFAT 47.67 4.45 3 1015
12 Transcriptional regulation by high
mobility group protein
46.49 1.01 3 1014
13 AKT signaling pathway 46.16 1.27 3 1014
14 PIN1 signaling pathway 44.61 3.72 3 1014
15 Huntingtin signaling pathway 44.45 4.16 3 1014
16 Transcriptional regulation by STAT 42.80 1.31 3 1013
17 Nucleophosmin signaling pathway 41.76 2.69 3 1013
18 Transcriptional regulation by p53 39.87 9.95 3 1013
19 CDK inhibitor signaling pathway 37.14 6.61 3 1012
20 Transcriptional regulation by FOXO 35.47 2.11 3 1011
2788 Cell Reports 14, 2784–2796, March 29, 2016 ª2016 The Authorlevels were positively correlated with 24-hr LA had circadian
phase values less than 12, during which the peak time of diurnal
oscillation of gene expression appeared less than 12 hr after
lights on, and genes with negative correlation had circadian
phase values greater than 12, with the exception of Acat2, in
which the peak time appeared more than 12 hr after lights on
(Figure 3C). Moreover, the correlation between expression levels
of somecircadian genes and 3-hr LA showedcircadian-like oscil-
lation (Figures S3A–S3D). The correlation curves were similar to
the circadian oscillations of these gene expression patterns in
the mouse brain and pituitary (Figures S3E–S3H; http://bioinf.
itmat.upenn.edu/circa/). These findings suggested that the tran-
scriptional regulatory machineries underlying variations in the
expression levels of these genes at the same time each day
among mutant mice may be partially shared with those gener-
ating the circadian rhythm of these genes. These findings led
us to postulate that transcriptional regulatorymachineries under-
lying the infradian rhythm of these genes’ expression may be
partially shared with those underlying the circadian rhythm.
cAMP and pCREB Levels in the DG Are Correlated with
LA during Infradian Oscillation
Intracellular cyclic AMP (cAMP) in the mouse suprachiasmatic
nuclei shows circadian oscillation and regulates clock gene tran-
scription via activation of the cAMP response element-binding
protein (CREB; Harrisingh and Nitabach, 2008; O’Neill et al.,
2008). Abnormalities in CREB signaling in neurons have been
suggested to be involved in bipolar disorder according to a
meta-analysis of genome-wide association study (GWAS) data-
sets (Nurnberger et al., 2014). Our bioinformatics analysis using
KeyMolnet for the genes exhibiting high correlations with 24-hr
LA showed significant enrichment in the transcriptional regula-
tion by the CREB pathway (Table 1). Levels of cAMP in the DG
were negatively correlated with 24-hr LA (Figure 3D). In the
mouse hippocampus, cAMP exhibits circadian oscillation, with
lower levels at night and higher levels during the day (Eckel-
Mahan et al., 2008). Extrapolating the findings to infradian oscil-
latory LA in Camk2a-HKO mice supports the idea that cAMP in
the hippocampal DG shows infradian oscillations in these mu-
tants, that is, high or low cAMP in mice at low or high LA states,
respectively.
Next, we examined the correlations between the expression
levels of genes related to regulation of cAMP synthesis and
24-hr LA. G protein-coupled receptors (GPCRs) modulate
cAMP synthesis, and G protein-linked signaling has been impli-
cated in mood regulation in the human brain (Tomita et al., 2013).
Therefore, we searched for GPCR genes in the list of genes
exhibiting correlations with 24-hr LA by querying GPCR gene
lists (Hinckley et al., 2005; Wong, 2003) and found 12 GPCR
genes (13 transcripts) in our gene list. Of the 13 transcripts, 6
and 7 were encoded by Gs- and Gi-coupled GPCR genes,
respectively (Table S3). Of the six transcripts encoded by
Gs-coupled GPCR genes, five were negatively correlated with
24-hr LA, which was significantly more than expected (c2(1) =
4.27, p = 0.039). In addition, the list of genes exhibiting
correlations with 24-hr LA (p < 0.05) included three members
of the phosphodiesterase (PDE) family (Pde1c, 1444067_at,
r = 0.376; Pde10a, 1419390_at, r = 0.363; and Pde11a,s
Table 2. IEGs Whose Expression Levels Were Correlated with LA during the Time Windows of Interest at a Significance Level of
p < 0.05
Gene Symbol
Correlation with 24-hr LA
Correlation with 3-hr LA Immediately
before Sampling
Correlation with LA during 60 min
Immediately before Sampling
Probe ID C.C. p Value Probe ID C.C. p Value Probe ID C.C. p Value
Arc NA NA 1418687_at 0.648 0.000014
Bdnf NA NA NA
Egr1 NA NA NA
Egr2 NA 1427682_a_at 0.392 0.0165 NA
Fos NA 1423100_at 0.461 0.0041 1423100_at 0.629 0.00003
Homer1 NA NA 1425710_a_at 0.367 0.0254
Homer2 NA NA NA
Jun 1417409_at 0.409 0.012 NA NA
Junb NA NA 1415899_at 0.566 0.0003
Narp NA NA 1420720_at 0.498 0.0017
Npas4 NA NA NA
Nr4a1 NA NA 1416505_at 0.396 0.0152
Nr4a2 NA 1450749_a_at 0.325 0.0494 NA
Nrn1 NA NA NA
Rgs2 NA NA 1447830_s_at 0.431 0.0077
C.C., correlation coefficient; p value, p value of correlation; NA, not applicable.1432999_at, r = 0.371; Table S1), which can downregulate intra-
cellular cAMP (Bender and Beavo, 2006; Soderling and Beavo,
2000; Wayman et al., 2005). The expression levels of these three
PDE genes were positively correlated with 24-hr LA, suggesting
that relatively high or low expression of these PDE genes may
result in low or high cAMP levels during high or low LA states,
respectively.
We also found that CREB phosphorylation levels in the DG
were negatively correlated with 24-hr LA (Figure 3E), with high
or low levels in the dentate granule cells of mice at low or high
LA states, respectively (immunoreactivity of phosphorylated
cAMP response element-binding protein, or pCREB, normalized
to CREB in the granule cell layer, a.u.: 0.61 ± 0.058 in the low LA
group, 0.43 ± 0.033 in the high LA group, means ± SEMs, n = 4
mice in each group, p = 0.038; Figure 3F). The pCREB is predom-
inantly expressed in NeuN-positive granule cells in the DG (Fig-
ure 3G). Considering that transcriptions of some circadian genes
are directly or indirectly regulated by cAMP and CREB (O’Neill
et al., 2008; Valor et al., 2010; Zhang et al., 2005), our results sug-
gested that alterations in the expression of the cAMP/CREB
pathway-related molecules could orchestrate the expression of
some circadian genes during infradian oscillation of LA in DG
granule cells. Previous findings showing that genetic and phar-
macological manipulations, which could decrease CREB phos-
phorylation, result in hyperlocomotion in rodents (Einat et al.,
2003; Prickaerts et al., 2006) are consistent with this idea.
Chronic Treatment of Camk2a-HKO Mice with a Mood
Stabilizer Alters Their LAs with Concomitant Changes in
pCREB Expression Levels in the DG
To examine whether infradian oscillatory LA and pCREB expres-
sion in the DG respond to mood stabilizer treatment, we treatedCellCamk2a-HKO mice with lamotrigine and carbamazepine, which
exert antidepressive effects (Calabrese et al., 1996; Kusumakar
and Yatham, 1997) and antimanic effects (Okuma et al., 1979;
Weisler et al., 2005), respectively, in the context of bipolar disor-
der. Lamotrigine has been reported to inhibit glutamate release
(Lee et al., 2008) and attenuate CREB phosphorylation (Ginty
et al., 1993) in the rodent brain. Subchronic carbamazepine
treatment has been shown to increase pCREB levels in neuronal
cell culture (Mai et al., 2002). In Camk2a-HKO mice, chronic la-
motrigine treatment was found to increase home cage LA (Fig-
ures 4A and 4B) with a concomitant trend toward decreased
pCREB expression in the DG (Figure 4C) compared to controls.
Chronic carbamazepine also decreased home cage LA (Figures
4D and 4E), with a concomitant increase in pCREB expression in
the DG (Figure 4F) compared to controls. Our findings were
consistent with previous observations showing the effects of
mood stabilizers on pCREB (Lee et al., 2008; Ginty et al., 1993;
Mai et al., 2002). These results, showing that LAs of Camk2a-
HKO mice responded to mood stabilizer treatment at clinically
relevant doses, support the predictive validity of these mutant
mice as a model of mood disorders. Furthermore, our results
showing that drugs affecting pCREB expression resulted in
changes in LA support the idea that pCREB levels in the brain
may modulate LA.
Correlations between Home Cage LA and the
Expression of Circadian Genes in the DG of
Schnurri-2-KO Mice
Finally, we examined whether the correlations between gene
expression patterns in the DG and LA states are specific to
Camk2a-HKOmice. To address the issue, we evaluated correla-
tions between these parameters using schnurri-2 knockoutReports 14, 2784–2796, March 29, 2016 ª2016 The Authors 2789
Figure 3. Expression Levels of Circadian Genes and cAMP/CREB Pathway Were Altered with Changes in LA during Infradian Oscillation
(A) Genes used to predict 24-hr LA. Genes shown in red represent circadian or circadian-regulated genes presented in the Photoperiodism database.
(B) Phase values in Figure 2C represent the peak times of circadian gene expression. The red and blue lines show the expression patterns of genes with circadian
phase values less than and greater than 12, respectively.
(C) Circadian genes in the list of genes exhibiting correlations with 24-hr LA (p < 0.01). Circadian phase values less than and greater than 12 are outlined with red
and blue lines, respectively.
(D) Scatter plot showing correlations between 24-hr LA and cAMP concentrations in the DG. The y axis is the cAMP concentration, obtained by ELISA analysis
and normalized to total protein amount.
(E) Top: representative blot images for pCREB and CREB frommice at low LA status (distance traveled: approximately 1.83 104 to 2.03 104 cm/24 hr) and high
LA status (distance traveled: approximately 9.53 104 to 1.33 105 cm/24 hr). Bottom: scatter plot showing correlations between 24-hr LA and pCREB level in the
DG. The y axis is the pCREB level normalized to total CREB expression, obtained by immunoblot analysis.
(F) Distribution of pCREB-positive cells in the DG of mice with low and high LA (see Experimental Procedures for details). g, granule cell layer; h, hilus;
m, molecular layer. Scale bar, 200 mm.
(G) Double immunostaining for pCREB, along with NeuN, in the granule cell layer. Arrowheads indicate examples of double-positive cells. Scale bar, 50 mm.
See also Figure S3 and Table S3.(Shn2-KO) mice and wild-type mice (Figure 5). We previously re-
ported that Shn2-KO mice show increased LA in the home
cage (but without clear infradian oscillation; Takao et al.,
2013). In Shn2-KO mice, the expression levels of 1,388 tran-
scripts (1,250 genes) were correlated with 24-hr LA (p < 0.01;
Figure 5B; Table S4). Genes exhibiting correlations with 24-hr
LA (p < 0.01) included a significantly larger number of circadian
genes than chance level (57 of 1,388 transcripts, c2(1) = 15.73,
p = 7.29 3 105; Table S4), although the gene expression
patterns did not accurately predict 24-hr LA with the method
used for predicting that of Camk2a-HKO mice (data not shown).2790 Cell Reports 14, 2784–2796, March 29, 2016 ª2016 The AuthorSimilarly, in wild-type mice, we found that expression levels
of 285 transcripts (283 genes) were correlated with 24-hr LA
(p < 0.01; Figure 5B; Table S4); however, the gene expression
patterns could not predict 24-hr LA. In contrast to Shn2-KO
mice, genes exhibiting correlations with 24-hr LA (p < 0.01)
did not include a significantly larger number of circadian genes
than chance level in wild-type mice (9 of 285 transcripts, c2(1) =
0.58, p = 0.45; Table S4). A meta-analysis of pathway enrich-
ment analysis using NextBio (Hagihara et al., 2014; Takao
and Miyakawa, 2015), in which two gene lists of 24-hr LA-
correlated genes in Camk2a-HKO mice and Shn2-KO mices
Figure 4. Chronic Treatment of Camk2a-HKO with Mood Stabilizers Altered Their LAs with Concomitant Changes in pCREB Expression in
the DG
(A) Home cage LAs of control (an average of 10 mice) and lamotrigine (LTG)-treated mice (an average of 11 mice).
(B) Effects of LTG treatment on LA. The average LAs during the period 45 days before and after the initiation of treatment were compared within individual mice.
**p < 0.01, two-tailed paired t test.
(C) Effects of LTG treatment on pCREB levels in the DG. g, granule cell layer. Scale bar, 200 mm. Bars represent mean ± SEM. #p < 0.1, Student’s t test.
(D) Home cage LAs of control (an average of ten mice) and carbamazepine (CBZ)-treated mice (an average of nine mice).
(E) Effects of CBZ treatment on LA. The average LAs during the period 50 days before and after the initiation of treatment were compared within individual mice.
*p < 0.05, two-tailed paired t test.
(F) Effects of CBZ treatment on pCREB levels in the DG. g, granule cell layer. Scale bar, 200 mm. Bars represent mean ± SEM. **p < 0.01, Student’s t test.were integrated, again identified CREB-related signaling path-
ways (Figure 5C).
DISCUSSION
In this study, we demonstrated that gene expression patterns in
the DG can retrospectively predict states of infradian rhythm
behavior,whichwere represented by 24-hr LA (LAof the timewin-
dowfrom6 to30hrbeforesampling;Figure2C).Onemight expect
that this result simply relies on the gene expressions affected by
LA immediately before sampling. However, the expressions of
some major immediate-early genes (IEGs; e.g., Fos, Egr2, and
Nr4a2; McNulty et al., 2012; VanElzakker et al., 2008) were corre-
lated with the 3-hr LA immediately before sampling but not with
the 24-hr LA (Table 2). In addition, none of these IEGs were
used in the 24-hr LA prediction model (Figure 3A). Moreover, in
the prediction analysis of 3-hr LA, gene expression patterns in
the DG could not predict LA during the 3 hr immediately before
sampling (Figure 2E), indicating that LA immediately before sam-Cellpling is not a major factor determining the gene expression pat-
terns in this brain region. These findings indicate that ourmicroar-
ray data used for LA predictions do not reflect LA immediately
before sampling. Thus, gene expression patterns in the DG also
hold information about behavioral states during specific timewin-
dows that are several hours or days apart from the sampling time.
Another main finding in this study is that circadian genes
exhibit infradian expression changes in the brain of Camk2a-
HKO mice. A recent study demonstrated that expressions of a
substantial number of genes, including circadian genes, display
annual periodicities in human white blood cells (Dopico et al.,
2015), demonstrating a long infradian periodicity of circadian
gene expressions. This circannual rhythm of gene expressions
was suggested to be human environmental adaptation, because
such gene expression levels were correlated with temperature
and sunlight hours (Dopico et al., 2015). In the present study,
however, mice weremaintained in the condition of constant tem-
perature and light-and-dark hours, suggestive of internally
generated rhythm of gene expressions in an infradian mannerReports 14, 2784–2796, March 29, 2016 ª2016 The Authors 2791
Figure 5. Correlations between Home Cage LA and Gene Expression Patterns in the DG of Shn2-KO Mice
(A) After monitoring home cage LA, the DG of wild-type mice (n = 9) and Shn2-KO mice (n = 6) sampled ZT6–ZT7 were processed for microarray analysis.
(B) Genes exhibiting significant correlations with 24-hr LA (p < 0.01) were partly overlapped among the three strains of mice. WT, wild-type.
(C) Meta-analysis identified the canonical pathways or biogroups over-represented in the genes exhibiting significant correlations with 24-hr LA (p < 0.01) in
Camk2a-HKO and Shn2-KO mice using NextBio. The top five pathways or biogroups are shown.
See also Table S4.in these mice. Among the circadian genes Dopico et al. (2015)
examined, circannual expression rhythm of ARNTL (BMAL1) in
human white blood cells was replicated in all five independent
cohorts they examined, in which BMAL1 expression was higher
in summer than in winter. Considering that physical activity of hu-
mans is higher in summer than in winter (Hesketh et al., 2014),
BMAL1 expression in human white blood cells may be positively
correlated with physical activity during a long seasonal infradian
rhythm, which is in accordance with our result showing positive
correlation between Bmal1 expression in the DG and 24-hr LA
(Figure 3C; Table S1). Regarding the relationships between
Bmal1 expression in the CNS and LA, mice lacking Bmal1 spe-
cifically in the CNS showed lower home cage LA compared
with control mice (Mieda and Sakurai, 2011). This was also
consistent with our results.
BMAL1 has been shown to be associatedwith bipolar disorder
(Mansour et al., 2006; Nievergelt et al., 2006). Deficiencies in
Bmal1 and Clock, a circadian gene regulated by Bmal1 protein
(Kondratov et al., 2003), alter sleep patterns in mice (Laposky
et al., 2005; Naylor et al., 2000), and sleep disturbances are
considered a symptom of the disorder (Jackson et al., 2003).
CLOCK has also been suggested as one of the susceptibility
genes for bipolar disorders from a multi-locus interaction anal-
ysis (Shi et al., 2008). The expression of Bmal1 and Clock in the
DG of Camk2a-HKO mice was correlated with 24-hr LA with
the same direction of correlation (Table S1), suggested that sleep
patterns may be altered with changes in LA states in these mice.
We also found that cAMP and pCREB levels in the DG were
negatively correlated with LA. It has been suggested that manip-2792 Cell Reports 14, 2784–2796, March 29, 2016 ª2016 The Authorulations leading to downregulation of CREB activation cause
increased LA in rodents (Einat et al., 2003; Prickaerts et al.,
2006). Rats treated with an inhibitor of mitogen-activated protein
kinase (MAPK)/extracellular signal-regulated kinase (Einat et al.,
2003), a positive regulator of CREB, and transgenic mice overex-
pressing Gsk3 (Prickaerts et al., 2006), which inhibits CREB
(Salas et al., 2003), exhibited elevated LA compared to control
animals. In addition, it has been reported that deficiency of
Pde10a, a molecule that can downregulate intracellular cAMP
(Soderling and Beavo, 2000) and whose expression is positively
correlated with 24-hr LA (Table S1), causes reduced LA (Sano
et al., 2008; Siuciak et al., 2006). These findings are consistent
with our results showing negative correlations between cAMP
and pCREB levels and LA during infradian rhythm behavior.
Abnormalities in CREB-related pathways have been impli-
cated in mood disorder (Coyle and Duman, 2003; Nestler et al.,
2002; Nurnberger et al., 2014). A meta-analysis integrating four
independent datasets of GWASs also identified signaling path-
ways related to protein kinase A (PKA), a cAMP-dependent
protein kinase that phosphorylates CREB, and CREB as the
over-represented pathways for bipolar disorder (Nurnberger
et al., 2014). In addition to the cAMP/PKA-mediated CREB
pathway, the protein kinase B (AKT) pathway, and the ras-
MAPK pathway (including ERK), other signaling pathways up-
stream of CREB are thought to be involved in mood disorders,
as shown by pharmacological studies onmood stabilizers (Coyle
and Duman, 2003). Our bioinformatics analysis also showed that
genes exhibiting high correlations with 24-hr LA were involved in
theMAPK and AKT signaling pathways (Table 1), suggesting thats
such pathways and the cAMP-mediated pathway may be
involved in mood change-like behaviors in Camk2a-HKO mice.
Downstream of CREB, although interleukin-6 and FOSB have
been implicated in mood disorders (Krishnan and Nestler,
2008), such genes were not found in the results of our analyses.
Instead, a signaling pathway related to the CREB target gene
Bcl2, which is also affected by mood stabilizers (Coyle and
Duman, 2003), was enriched in the genes exhibiting high corre-
lations with 24-hr LA (Table 1). These results suggested that
some upstream and downstream pathways of CREB implicated
in mood disorders were related to infradian oscillatory LA in
Camk2a-HKO mice.
Previous studies on human and animal models indicated an
association of CAMK2 genes with mood disorders, including bi-
polar disorder (Ament et al., 2015; Le-Niculescu et al., 2009; Ro-
bison, 2014; Shin et al., 2013; Xing et al., 2002; Yamasaki et al.,
2008). Decreased expression of Camk2a mRNA has been re-
ported in postmortem analysis of the brain from patients with
bipolar disorder (Xing et al., 2002). Hyperexcitability of DG neu-
rons, which we identified in Camk2a-HKO mice in previous
studies (Hagihara et al., 2013; Yamasaki et al., 2008), has been
suggested in patients with bipolar disorder by using iPSC tech-
nology (Mertens et al., 2015). Moreover, in the present study,
we found that infradian oscillatory LA of Camk2a-HKO mice re-
sponded tomood stabilizer treatment (Figure 4). Thus, these pre-
vious reports, together with the present study, indicated that
Camk2a-HKO mice displayed construct, face, and predictive
validity and may be useful in elucidating the pathogenesis and
pathophysiology of bipolar disorder.
In addition to Camk2a-HKO mice, we found correlations be-
tween LA and gene expression in the DG by simple correlation
analysis in Shn2-KO mice, which showed hyperactivity in the
home cage. Knockdown of Shn2, a major histocompatibility
complex enhancer binding protein, causes atypical inflammation
and associated hippocampal and cortical abnormalities, which
may induce a series of schizophrenia-related behavioral abnor-
malities in mice (Takao et al., 2013). As observed in Camk2a-
HKO mice, circadian genes were concentrated in the genes
exhibiting significant correlations with 24-hr LAs in Shn2-KO
mice. These results suggested that LA-related gene regulation
in the DG may be partly common among these mice.
Accumulating evidence from human studies, including volu-
metric and functional evaluations using MRI, has suggested
that the hippocampus is a core region for mood disorders (Ber-
tolino et al., 2003; Brown et al., 1999; Campbell et al., 2004; Chen
et al., 2010; Femenı´a et al., 2012; Nestler et al., 2002). In addition,
adult neurogenesis in the hippocampal DG has been suggested
to have an important role in the pathophysiology of mood disor-
ders and in mediating the response to antidepressants (Duman
et al., 2001; Samuels and Hen, 2011). In this context, we exam-
ined the relationships between gene expression patterns in the
DG and infradian oscillatory LA. We found significant correla-
tions between expression of some circadian genes and behav-
iors in the present study. However, it will be interesting to
examine whether the expression of circadian genes shows infra-
dian rhythms in other brain regions, such as cornu ammonis (CA)
areas in the hippocampus and the bed nucleus of the stria termi-
nalis, in which, similar to the DG, abnormal cellular activities haveCellbeen found in Camk2a-HKO mice from an in vivo manganese-
enhanced MRI study (Hattori et al., 2013).
In conclusion, our results showed that statistical learning
models using gene expression patterns in the DG can predict
the behavioral state of individual mice showing exaggerated in-
fradian rhythm. This is the first demonstration, to our knowledge,
of successful quantitative predictions of the individual behavioral
state frommolecular expression patterns in the brain. Moreover,
informatics analyses of genes used in the prediction models
showed concomitant changes in the expression levels of
multiple circadian genes in the brain and states of infradian
rhythm behavior, providing the evidence for a novel concept
that some circadian genes may be involved in the generation
of infradian rhythm behavior. Further studies are needed to




We used Camk2a-HKO mice (Yamasaki et al., 2008), Shn2-KO mice (Takao
et al., 2013), and wild-type mice. All animal experiments were approved by
the Institutional Animal Care and Use Committee of Fujita Health University,
based on the Law for the Humane Treatment and Management of Animals
and the Standards Relating to the Care and Management of Laboratory
Animals and Relief of Pain. Every effort was made to minimize the number of
animals used.
LA Monitoring in the Home Cage and Sampling
LA monitoring in the home cage was performed with adult male mice over
8 weeks of age as previously described (Yamasaki et al., 2008). In Camk2a-
HKO mice, LAs in their home cage gradually and greatly change over time,
with an approximate cycle length of 10–20 days (Yamasaki et al., 2008). To
ensure variations in LAs of the sampled mice, up to eight mice with short or
long distances traveled (assessed by distance traveled during the 24 hr before
ZT0 on the sampling day) were preferentially sampled ZT6–ZT7 of the sam-
pling day. This process was repeated as needed. To minimize the influence
of individual differences in LAs immediately before sampling on the gene
expression patterns in the DG, we sampled ZT6–ZT7, before which the mutant
mice showed relatively similar LAs.
Open Field Test and Porsolt Forced Swim Test
An open field test and the Porsolt forced swim test were conducted as previ-
ously described (Takao et al., 2013; Yamasaki et al., 2008). See the Supple-
mental Information for details.
Lamotrigine and Carbamazepine Treatment
Lamotrigine was administered in drinking water to Camk2a-HKO mice, aiming
at 30 mg/kg/day. Carbamazepine was administered in the diet to Camk2a-
HKO mice at dietary levels of 0.75%. See the Supplemental Information for
details.
Expression Microarray Analysis
Dissection of mice DG (Hagihara et al., 2009) and microarray experiments (Ta-
kao et al., 2013; Yamasaki et al., 2008) were performed as described previ-
ously. See the Supplemental Information for details. The microarray data
were deposited in the GEO database under accession number GEO:
GSE68293.
Cross-validated LA Prediction
Leave-two-out cross-validation prediction of LA (24- and 3-hr LAs) was per-
formed with MATLAB using log2-transformed gene expression values for indi-
vidual mice. See the Supplemental Information for details.Reports 14, 2784–2796, March 29, 2016 ª2016 The Authors 2793
Bioinformatics Analysis of Gene Expression Data
Bioinformatics analyses of the lists of genes exhibiting correlations with 24-hr
LAs were performed using KeyMolnet (KM Data), DAVID (https://david.ncifcrf.
gov/), or NextBio (Illumina). See the Supplemental Information for details.
Querying the Database for Circadian Gene Expression Patterns
To determine howmany circadian genes were included in our gene list, we first
queried the Photoperiodism database, which presents genes showing circa-
dian expression patterns within a 24-hr period in short-day and long-day
conditions in the adult mouse pars tuberalis (Masumoto et al., 2010). We
considered the genes in our lists to be circadian genes when we found the
genes in the database by searching with the Affymetrix probe set IDs (Figure 3;
Tables S1, S2, and S4). Phase values in Figure 3C referred to those from the
short-day condition. Expression patterns of the circadian genes were obtained
from the CircaDB database. We searched the database with gene symbols
and used data describing circadian expression patterns in the mouse brain
and pituitary (Figure S3).
Measurement of cAMP Concentrations
Measurement of cAMP concentrations in the DG was performed with another
set of mice (n = 42) that was used for microarray analysis. The isolated DG (Ha-
gihara et al., 2009) was sonicated in 50 ml of 0.1MHCl, and the suspensionwas
centrifuged at 1,000 3 g. The supernatant was diluted at 1:500 and used to
measure cAMP levels according to the manufacturer’s instructions (Cayman
Scientific). Protein concentrations were measured using Bradford assays
(Thermo Scientific). Data obtained from two independent experiments were
combined and shown in Figure 3D.
Immunological Detection of pCREB
The isolatedDG (Hagihara et al., 2009) was homogenized and separated by gel
electrophoresis, transferred to polyvinylidene difluoride membranes, and
probed with anti-pCREB antibody (Cell Signaling Technology, 9198,
1:1,000), rabbit anti-CREB antibody (Cell Signaling Technology, 9197,
1:1,000), or mouse anti-b-actin antibody (Sigma-Aldrich, A5316, 1:30,000).
Immunoreactivity was quantified using ImageMaster software (GE Health-
care). This analysis was performed with a set of mice (n = 43) that was partially
overlapped with the set used in cAMP measurement analysis. Data obtained
from three independent experiments were combined and shown in Figure 3E.
A separate set of mice was used for immunohistochemical analyses (Fig-
ures 3 and 4). Mice with high LA (distance traveled: approximately 9.0 3 104
to 1.2 3 105 cm/24 hr; n = 4) and low LA (distance traveled: approximately
1.53 104 to 2.73 104 cm/24 hr; n = 4) were processed for immunohistochem-
ical analyses (Figure 3F). Frozen sections were probed with rabbit anti-pCREB
antibody (1:100), anti-CREB antibody (1:2,000), or mouse anti-NeuN antibody
(Millipore, MAB377, 1:100). Quantification of the immunofluorescence inten-
sities of CREB and pCREB was performed using ZEN software (Zeiss). See
the Supplemental Information for details.
Statistical Analysis
Chi-square values were calculated from the differences between the observed
and the expected number of genes. Significance was defined as a p value of
less than 0.05. Immunohistochemical data were analyzed with unpaired Stu-
dent’s t test, and differences were considered significant when the p value
was less than 0.05.
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